Insights

Written by Carolyn O’Connor and Thomas Jordan on June 5th, 2019

Glyphosate Update

Claims alleging glyphosate’s role in causing non-Hodgkin lymphoma have increased exponentially in recent years, driven largely by disputes involving chemical giant Monsanto.  While the preponderance of related trials and appeals have been venued in the U.S., there is a great deal of attention being paid this topic in the UK. 

In this article, Wilson Elser partner Carolyn O’Connor and DACB associate Thomas Jordan present an in-depth account of the differences in how cases are handled and the resulting pace with which claims are brought against Monsanto and other glyphosate manufacturers. 

Read the full article.

Contact Person(s)

DAC Beachcroft, Wilson Elser
Regulatory Compliance
North America, Europe